Acetylation of C/EBPα inhibits its granulopoietic function

[1]  Siew K. Yeap,et al.  Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation , 2014, Journal of medicinal chemistry.

[2]  D. Leahy,et al.  Regulation of S-Adenosylhomocysteine Hydrolase by Lysine Acetylation* , 2014, The Journal of Biological Chemistry.

[3]  J. F. Amacher,et al.  Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain , 2014, PloS one.

[4]  A. Haman,et al.  RARα-PLZF oncogene inhibits C/EBPα function in myeloid cells , 2013, Proceedings of the National Academy of Sciences.

[5]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. , 2013, The journal of physical chemistry. B.

[6]  K. Akashi,et al.  C/EBPα is required for development of dendritic cell progenitors. , 2013, Blood.

[7]  Jiuhong Kang,et al.  Lysine Acetyltransferase GCN5 Potentiates the Growth of Non-small Cell Lung Cancer via Promotion of E2F1, Cyclin D1, and Cyclin E1 Expression* , 2013, The Journal of Biological Chemistry.

[8]  D. Tenen,et al.  C/EBPa controls acquisition and maintenance of adult hematopoietic stem cell quiescence , 2013, Nature Cell Biology.

[9]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[10]  D. Tenen,et al.  Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα. , 2012, The Journal of clinical investigation.

[11]  Eric T. Kim,et al.  Regulation of RAS oncogenicity by acetylation , 2012, Proceedings of the National Academy of Sciences.

[12]  Tingjun Hou,et al.  Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..

[13]  Li-Rong Yu,et al.  Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivation , 2011, The EMBO journal.

[14]  S. Shurtleff,et al.  Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  M Cazzola,et al.  Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells , 2010, Leukemia.

[16]  M. Mann,et al.  Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions , 2009, Science.

[17]  P. Puigserver,et al.  GCN5-mediated Transcriptional Control of the Metabolic Coactivator PGC-1β through Lysine Acetylation* , 2009, The Journal of Biological Chemistry.

[18]  Daniel G Tenen,et al.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Y. Duan,et al.  Effects of posttranslational modifications on the structure and dynamics of histone H3 N-terminal Peptide. , 2008, Biophysical journal.

[20]  S. Dent,et al.  Proper expression of the Gcn5 histone acetyltransferase is required for neural tube closure in mouse embryos , 2008, Developmental dynamics : an official publication of the American Association of Anatomists.

[21]  S. Bohlander,et al.  Proteomic identification of the MYST domain histone acetyltransferase TIP60 (HTATIP) as a co-activator of the myeloid transcription factor C/EBPα , 2008, Leukemia.

[22]  G. Behre,et al.  Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPα by inhibiting its ubiquitination , 2007, Oncogene.

[23]  J. Tomlinson,et al.  Glucocorticoid-stimulated preadipocyte differentiation is mediated through acetylation of C/EBPβ by GCN5 , 2007, Proceedings of the National Academy of Sciences.

[24]  Ray Luo,et al.  How well does Poisson-Boltzmann implicit solvent agree with explicit solvent? A quantitative analysis. , 2006, The journal of physical chemistry. B.

[25]  P. Puigserver,et al.  GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. , 2006, Cell metabolism.

[26]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[27]  S. Bohlander,et al.  Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations , 2006, The Journal of experimental medicine.

[28]  R. Costa,et al.  C/EBPα and HNF6 protein complex formation stimulates HNF6‐dependent transcription by CBP coactivator recruitment in HepG2 cells , 2006, Hepatology.

[29]  A. Fukamizu,et al.  Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Marie S. Hasemann,et al.  Loss of C/EBPα cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage , 2005, The Journal of experimental medicine.

[31]  Pu Zhang,et al.  Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha. , 2004, Immunity.

[32]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[33]  J. Rowley,et al.  The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Tenen,et al.  Phosphorylation of C/EBPα Inhibits Granulopoiesis , 2004, Molecular and Cellular Biology.

[35]  C. Smith,et al.  The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions. , 2003, Journal of immunological methods.

[36]  D. Tenen,et al.  The amino terminal and E2F interaction domains are critical for C/EBP alpha-mediated induction of granulopoietic development of hematopoietic cells. , 2003, Blood.

[37]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[38]  Maria Miller,et al.  Structural Basis for DNA Recognition by the Basic Region Leucine Zipper Transcription Factor CCAAT/Enhancer-binding Protein α* , 2003, The Journal of Biological Chemistry.

[39]  A. Viale,et al.  Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells. , 2003, Blood.

[40]  Mark Coles,et al.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre , 2003, European journal of immunology.

[41]  J. Iñiguez-Lluhí,et al.  A Synergy Control Motif within the Attenuator Domain of CCAAT/Enhancer-binding Protein α Inhibits Transcriptional Synergy through Its PIASy-enhanced Modification by SUMO-1 or SUMO-3* , 2003, The Journal of Biological Chemistry.

[42]  Peter F. Johnson,et al.  Transcriptional Activity of CCAAT/Enhancer-binding Proteins Is Controlled by a Conserved Inhibitory Domain That Is a Target for Sumoylation* , 2002, The Journal of Biological Chemistry.

[43]  E. Park,et al.  Conserved Amino Acids within CCAAT Enhancer-binding Proteins (C/EBPα and β) Regulate Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression* , 2002, The Journal of Biological Chemistry.

[44]  Roland L. Dunbrack.  Rotamer libraries in the 21st century. , 2002, Current opinion in structural biology.

[45]  K. Akashi,et al.  Induction of granulocytic differentiation by 2 pathways. , 2002, Blood.

[46]  B. Porse,et al.  E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo , 2001, Cell.

[47]  O. MacDougald,et al.  p300 Coactivates the Adipogenic Transcription Factor CCAAT/Enhancer-binding Protein α* , 2001, The Journal of Biological Chemistry.

[48]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[49]  R. Skeel,et al.  Langevin stabilization of molecular dynamics , 2001 .

[50]  K. Ozato,et al.  Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Yvonne A. Evrard,et al.  Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development , 2000, Nature Genetics.

[52]  D. Tenen,et al.  CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.

[53]  D. Tenen,et al.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Tenen,et al.  PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. , 1996, Blood.

[55]  S. McKnight,et al.  The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite. , 1989, Science.

[56]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[57]  J. Greenberger,et al.  Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[58]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[59]  D. Tenen,et al.  Phosphorylation of C/EBPalpha inhibits granulopoiesis. , 2004, Molecular and cellular biology.

[60]  E. Park,et al.  Conserved amino acids within CCAAT enhancer-binding proteins (C/EBP(alpha) and beta) regulate phosphoenolpyruvate carboxykinase (PEPCK) gene expression. , 2002, The Journal of biological chemistry.

[61]  M. Caligiuri,et al.  BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. , 2002, Nature genetics.

[62]  M. Caligiuri,et al.  BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2 , 2002, Nature Genetics.

[63]  G. Behre,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. , 2001, Nature genetics.

[64]  D. Tenen,et al.  Use of a promoterless Renilla luciferase vector as an internal control plasmid for transient co-transfection assays of Ras-mediated transcription activation. , 1999, BioTechniques.